Lapsed Mar 12, 2025 on the fee record · High confidence
20-year base term ended Sep 17, 2024
Third maintenance fee unpaid; grace period ended.
Held by Nektar Therapeutics
Filed Nov 30, 2007 as application 11/948,767 · Granted Mar 12, 2013
Base term, 20 years from filing, plus 1211 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
Lapsed Mar 12, 2025
2004
2026
Clock starts
Sep 17, 2004
Sep 17, 2004
No longer in force
Mar 12, 2025
Mar 12, 2025
Granted
Mar 12, 2013
Mar 12, 2013
Term would have run to
Dec 8, 2026
Dec 8, 2026
base term
patent term adjustment
after the term ends
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,211
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 7,744,861.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
Its term would have run to Dec 8, 2026: its 20-year base term plus 1211 days of term adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 17, 2004, when application 10/943,799, the earliest non-provisional in its chain, was filed (this one was filed Nov 30, 2007) | Sep 17, 2024 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1211 days, USPTO patent term adjustment record | Jan 11, 2028 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,744,861) | capped to Dec 8, 2026 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | lapsed Mar 12, 2025 | High confidence |
| Computed term end | The steps above, in order | Mar 12, 2025 | High confidence |
This family
| US 7,744,861 | In force Dec 2026 | Dec 2026 |
| US 8,394,365 | this patent Mar 2025 | Mar 2025 |
| Application 12/069,727 | Abandoned not computed | not computed |
| US 8,263,062 | Lapsed on the fee record Sep 2024 | Sep 2024 |
| US 8,318,145 | Term ended no later than Sep 2024 | no later than Sep 2024 |
| US 8,771,662 | Term ended Sep 2024 | Sep 2024 |
| US 9,333,200 | Lapsed on the fee record May 2024 | May 2024 |
| US 9,808,533 | Term ended Sep 2024 | Sep 2024 |
8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 15, 2008 Reel 20519, frame 739 | Zhao, Xuan; Bentley, Michael David; Ren, Zhongxu; Viegas, Tacey X. | Nektar Therapeutics Al, Corporation | Assignment of Assignor's Interest |
| Feb 15, 2008 Reel 20561, frame 298 | Zhao, Xuan; Bentley, Michael David; Ren, Zhongxu; Viegas, Tacey X. | Nektar Therapeutics Al. Corporation | Assignment of Assignor's Interest |
| Aug 31, 2009 Reel 23196, frame 394 | Nektar Therapeutics Al, Corporation | Nektar Therapeutics | Merger |
| Jul 17, 2012 Reel 28571, frame 141 | Nektar Therapeutics | Wells Fargo Bank, National Association, as Collateral Agent | Grant of Security Interest |
| Oct 6, 2015 Reel 36796, frame 562 | Nektar Therapeutics | TC Lending, LLC, as Collateral Agent | Grant of Security Interest in United States Patents |
| Oct 14, 2015 Reel 36866, frame 700 | Wells Fargo Bank, National Association, as Collateral Agent | Nektar Therapeutics | Release of Security Interest Recorded at Reel 28571, Frame 0141 |
| Apr 17, 2020 Reel 53180, frame 9 | TC Lending, LLC, as Collateral Agent | Nektar Therapeutics | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 1211 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 7,744,861.
Citations
20
later US patents cite this one
That is above the median of utility patents granted in 2013 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.